Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,847 total articles
National Energy Services Reunited (NESR) has more than doubled from its 52-week low and recently rallied on new cementing contracts, yet the company still trades at a market cap roughly in line with 1.6x trailing revenue and technicals show room to run if execution on new wins proceeds. This trade idea lays out a precise entry at $20.35, stop loss …
VNET Group provides a play on accelerating AI and cloud demand in China while trading well below recent peak levels. The shares look constructive near $9.70 with a clear stop and upside toward prior highs if revenue and margin trends stabilize.
Energy Transfer (ET) offers a 7%+ distribution yield, solid distributable cash flow coverage, and a string of near-term catalysts — from SPR flows to AI-driven gas demand — that justify a tactical long position. Balance sheet leverage and macro risk require a disciplined entry and stop.
Markel (MKL) combines durable insurance underwriting, a growing Markel Ventures platform and a large investment float. At roughly $24.3B market cap and trading near $1,930, the stock sits at ~12x earnings, ~1.33x book and EV/EBITDA of ~7.8 — valuation levels that read like an opportunity for long-term investors. This trade idea lays out a disciplin…
Palantir shares trade with stretched multiples, but recent results and a new Nvidia partnership make a case for upside as enterprise adoption of agentic AI moves from pilots to operations. This trade idea lays out an entry at $154.35, a stop at $140.00 and staged targets at $180.00 and $207.52, with a clear horizon and risk plan.
Coinbase's Q1 guidance and recent regulatory tailwinds removed a major overhang. With a $53B market cap, improving technicals, and strong liquidity metrics, this is a tactical long trade sized to a mid-term horizon. Entry $195, stop $170, target $260 - horizon 45 trading days.
Bilibili shows durable DAU-led monetization and an ad rebound that is already lifting margins. With a market cap near $11.0B, improving operating profit and a recent string of positive quarters justify a tactical long in the mid term (45 trading days). Trade plan, catalysts and risks laid out below.
Emeren Group Ltd (SOL) is a small-cap renewable developer trading near multi-month technical support. The company generates the majority of its revenue from electricity generation and operates across China and key European markets. With a market cap under $100M, constructive moving averages, and a manageable short-interest profile, SOL offers a hig…
MP Materials (MP) is the dominant U.S. rare-earth producer with a newly integrated processing-to-magnetics footprint. With market cap around $10.45B, EV roughly $10.37B, and tangible government and commercial contracts supporting higher realized prices, MP looks set to capture margin expansion as the industry faces a structural heavy-rare-earth def…
SentinelOne reported milestone results and guidance that disappointed some traders, but fundamentals and technicals argue for a disciplined long. A mid-term swing trade with a clear stop and a $19 target balances upside from re-rating and partnerships against execution and macro risks.
Apple's combination of premium hardware, tight software integration, and a massive services annuity positions it to monetize the next wave of AI without abandoning the company's design-first playbook. Valuation is elevated but supported by $123.3B free cash flow and an EPS of $8.02. We upgrade to a constructive rating and lay out an actionable trad…
Pfizer ($PFE) looks well positioned for a mid-term rebound. The stock is trading near $27 with a market cap around $156B, strong free cash flow (~$10.4B) and a chunky dividend yield (~6.2%). Recent positive oncology data and a new approval reduce headline risk, while technicals and heavy short interest create conditions for an outsized bounce. This…
Celestica is increasingly exposed to the AI data-center build cycle via a new AMD partnership and has the balance sheet and cash flow to scale production. The shares trade at premium multiples, but the combination of high ROE, accelerating enterprise wins and clean leverage makes a calculated long trade attractive for traders willing to hold throug…
DocuSign appears to be turning a corner: subscription stability, nearly $1B in free cash flow, and a sub-$10B enterprise value give investors a priced-in bear case. This trade idea lays out a concrete long entry, stop, and target with a 180-trading-day horizon, balancing upside from product-led AI adoption against execution and sector risks.
GSK is executing a clear playbook: grow vaccines and specialty franchises, accelerate oncology and HIV investments via pipeline and selective buys, and defend margins with commercial scale. The stock trades at a reasonable multiple for a major pharma and yields ~3.3%. We like a long exposure with disciplined risk management, targeting a move back t…
Las Vegas Sands is a cash-generative play on Asia-facing destination resorts. Recent beats in revenue and adjusted property EBITDA, combined with $1.86B of free cash flow and an EV/EBITDA of ~10.7, make a mid-term long trade attractive. Risks center on Macao margin pressure and leverage, but the balance sheet and Singapore earnings cushion the thes…
Upbound Group (UPBD) trades like a carved-out distressed rental business, but its balance sheet generates substantial free cash flow, an 8%+ dividend yield, and an EV/EBITDA of ~1.3. For investors willing to stomach leverage and economic cyclicality, a long trade into $18.10 with a $27.00 target and $15.50 stop offers asymmetric reward over a 180-t…
Transocean’s all-stock acquisition of Valaris, a growing $6.1B backlog, and strong operating cash flow create a pathway for meaningful value realization as deepwater project sanctioning accelerates into 2027. This trade targets $10.00 over a 180 trading-day horizon with a $4.50 stop to limit downside from merger and cycle risk.
DocuSign's pullback has left a high-quality SaaS business trading at rational multiples with nearly $1.0B in free cash flow, no net debt and intensifying AI product momentum. This trade targets a re-rating catalyzed by macro calm and improving revenue-per-customer metrics; enter at market, stop below the 52-week low neighborhood, target a 30-40% ra…
Millicom (TIGO) is executing a clear M&A playbook in Latin America that should materially lift free cash generation once integrations finish. With market cap at $12.35B, a modest P/E of 9.4x and a 4% yield, the stock looks positioned for a re-rate if the company delivers roughly $330M in incremental EFCF from consolidation in Colombia and Ecuador. …
HIVE Digital is repositioning itself from a pure-play Bitcoin miner to a hybrid operator that sells GPU AI compute and partners with robotics firms. Market cap sits at roughly $564M and the stock trades near $2.23. I think the AMC Robotics collaboration and HIVE's green data-center footprint create meaningful optionality over the next 180 trading d…
Builders FirstSource (BLDR) is trading near its 52-week low despite solid free cash flow, a constructive balance sheet, and visible catalysts. This is a tactical long idea to build a position now with a clear entry, stop and target and a plan that leans on both fundamentals and technical oversold conditions.
Thermo Fisher (TMO) is a diversified life-science platform with durable free cash flow, exposure to accelerating markets such as molecular diagnostics, genomics services and biopharma CMO, and a balance sheet that supports growth and M&A. Recent price weakness has pushed technicals into oversold territory while fundamentals remain intact. This trad…
Matador Resources (MTDR) is trading at a steep valuation discount - EV/EBITDA ~4.4x and P/E ~9.4 - while insiders have been heavily accumulating. The combination of cash generation, rising production and midstream optionality offers an attractive mid-term trade. Entry $57.64, target $75.00, stop $50.00; time horizon: mid term (45 trading days).
Richmond Mutual's merger with Farmers Bancorp, consistent dividend policy and attractive book-valuations underpin a Buy. We lay out an actionable trade with entry, stop and target across a 180-day horizon while highlighting legal and execution risks tied to the proposed deal.
